GALECTIN THERAPEUTICS INC (GALT) Net Income (Loss) Attributable to Parent USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Galectin Therapeutics Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2024.
  • Galectin Therapeutics Inc Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$11.5 M, a 0.33% increase year-over-year.
  • Galectin Therapeutics Inc Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$41 M, a 1.63% decline year-over-year.
  • Galectin Therapeutics Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$41.1 M, a 5.91% decline from 2022.
  • Galectin Therapeutics Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$38.8 M, a 27% decline from 2021.
  • Galectin Therapeutics Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$30.5 M, a 30.1% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$41 M -$11.5 M +$38 K +0.33% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$41.1 M -$10 M +$637 K +5.99% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 -$41.7 M -$10.4 M -$1.83 M -21.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$39.9 M -$9.11 M +$499 K +5.19% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$40.4 M -$11.5 M -$1.6 M -16.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$38.8 M -$10.6 M -$3.41 M -47.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 -$35.4 M -$8.6 M -$77 K -0.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$35.3 M -$9.61 M -$1.16 M -13.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$34.1 M -$9.93 M -$3.59 M -56.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$30.5 M -$7.22 M +$632 K +8.05% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$31.2 M -$8.52 M -$2.58 M -43.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$28.6 M -$8.45 M -$2.34 M -38.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$26.2 M -$6.34 M -$2.78 M -78.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$23.5 M -$7.85 M -$2.72 M -52.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$20.8 M -$5.94 M -$3.16 M -113% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$17.6 M -$6.11 M -$3.12 M -104% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$14.5 M -$3.56 M -$1.18 M -49.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$13.3 M -$5.14 M -$2.09 M -68.4% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 -$11.2 M -$2.78 M -$32 K -1.16% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$11.2 M -$3 M +$842 K +21.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$12 M -$2.38 M +$1.88 M +44.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$13.9 M -$3.05 M -$668 K -28% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$13.2 M -$2.75 M +$1.66 M +37.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$14.9 M -$3.84 M +$668 K +14.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$15.6 M -$4.26 M +$679 K +13.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$16.2 M -$2.38 M +$2.21 M +48.1% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-06
Q3 2017 -$18.4 M -$4.41 M +$118 K +2.61% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$18.6 M -$4.51 M +$1.01 M +18.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$19.6 M -$4.94 M +$1.86 M +27.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 -$21.4 M -$4.59 M +$80 K +1.71% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-29
Q3 2016 -$21.5 M -$4.53 M +$1.36 M +23.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$22.9 M -$5.52 M -$876 K -18.9% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$22 M -$6.8 M -$1.97 M -40.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$20 M -$4.67 M -$940 K -25.2% Oct 1, 2015 Dec 31, 2015 10-K 2016-03-15
Q3 2015 -$19.1 M -$5.89 M -$2.37 M -67.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 -$16.7 M -$4.64 M -$1.21 M -35.4% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$15.5 M -$4.83 M +$284 K +5.56% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$15.8 M -$3.73 M -$932 K -33.3% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 -$14.9 M -$3.52 M +$24 K +0.68% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-15
Q2 2014 -$14.9 M -$3.43 M -$885 K -34.8% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-15
Q1 2014 -$14 M -$5.11 M -$1.91 M -59.5% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-15
Q4 2013 -$12.1 M -$2.8 M -$423 K -17.8% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-18
Q3 2013 -$11.7 M -$3.54 M -$853 K -31.7% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-18
Q2 2013 -$10.8 M -$2.54 M +$116 K +4.36% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-18
Q1 2013 -$10.9 M -$3.2 M -$1.25 M -64.3% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-18
Q4 2012 -$9.68 M -$2.38 M +$992 K +29.5% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-18
Q3 2012 -$10.7 M -$2.69 M -$661 K -32.6% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 -$10 M -$2.66 M +$467 K +14.9% Mar 29, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$10.5 M -$1.95 M +$442 K +18.5% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 -$10.9 M -$3.37 M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-29
Q3 2011 -$2.03 M -$919 K -82.9% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 -$3.13 M -$1.47 M -89.1% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-10
Q1 2011 -$2.39 M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-11
Q3 2010 -$1.11 M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-10
Q2 2010 -$1.65 M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.